Loading…
Operates in Pharma — Distribution. Per the activity note to the FY2024 annual report, the company trades pharmaceutical medicines at retail and wholesale.
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | CAGR |
|---|---|---|---|---|---|---|---|---|
| 3,579 | 4,365 | 3,891 | 3,065 | 3,900 | 3,914 | 3,129 | -2.2% | |
| 3,323 | 3,454 | 2,738 | 3,408 | 2,832 | 5,078 | 6,066 | +10.6% | |
| TOTAL ASSETS | 6,901 | 7,819 | 6,629 | 6,473 | 6,732 | 8,991 | 9,195 | +4.9% |
| 1,034 | 1,253 | 891 | 1,730 | 149 | 1,536 | 743 | -5.4% | |
| 403 | 937 | 462 | 940 | 1,146 | 1,364 | 904 | +14.4% | |
| TOTAL LIABILITIES | 1,437 | 2,190 | 1,353 | 2,671 | 1,295 | 2,900 | 1,647 | +2.3% |
| Total Equity | 5,465 | 5,629 | 5,277 | 3,802 | 5,437 | 6,091 | 7,548 | +5.5% |
| Balance Check (Assets - L&E) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Debt analysis | ||||||||
| Total Debt | 0 | 759 | 462 | 940 | 1,026 | 1,794 | 1,008 | +5.8% |
| Cash & Equivalents | 317 | 525 | 263 | 359 | 187 | 141 | 1,050 | +22.1% |
| Net Debt | 317 | 235 | 198 | 581 | 840 | 1,653 | 42 | -28.6% |
Shareholders, directors and group links from the companyinfo.ge public register — as filed, so stakes need not sum to 100% where a holding is undisclosed.
Ownership & directors from companyinfo.ge (public corporate registry).
Ranked by how close each latest revenue is to this one — not a curated comp set. Open this set in Compare →